List of the Top On-Prem Drug Discovery Software in 2026

Xybion LIMS is a comprehensive digital laboratory solution that integrates LIMS, ELN, QMS, and DMS to streamline workflows tailored to the specific requirements of regulated laboratories, such as those in research, diagnostics, quality control, and stability studies, among others. This platform enhances consistency and data quality while facilitating adherence to regulatory standards, offering a holistic laboratory management solution that seamlessly interfaces with your existing operating systems and includes robust laboratory information management and analytics features. By employing Xybion LIMS, laboratories can optimize their operations and ensure that they meet the evolving demands of their industries.

Nanome is an innovative platform that facilitates collaborative molecular visualization and enhances drug discovery efforts. Users can conveniently upload protein and small-molecule structures to analyze together in a three-dimensional view, which can be accessed via web browsers or various XR headsets, including the Meta Quest 3 and 3S, Apple Vision Pro, and Samsung Galaxy XR. In a collaborative session, participants, such as a chemist using a headset alongside a colleague on a laptop, can collectively focus on the same molecular aspects regardless of their physical locations. The platform is equipped with MARA, an AI copilot that adeptly handles tasks such as docking, co-folding, electrostatics calculations, and ADMET predictions by interpreting simple, natural language commands and utilizes more than 300 integrated scientific tools to generate 3D models for deeper analysis. Furthermore, Nanome accommodates a wide range of file formats including PDB, mmCIF, SDF, MOL2, PyMOL, and Maestro, and it connects seamlessly with various platforms like Schrodinger LiveDesign, OpenEye, Cresset Flare, CDD Vault, KNIME, and Jupyter. For enterprises, deployment options are available in single-tenant or on-premises configurations, which bolster security and governance. Users can access a free web seat, and there's a trial period of 14 days that does not require a credit card for initiation. By bridging the gap between technology and molecular science, Nanome is truly transforming the collaborative landscape for research teams.

StarDrop™ is an all-encompassing software suite that offers cutting-edge in silico technology, all presented within an intuitive visual framework. By facilitating a smooth transition between up-to-date data, predictive modeling, and strategic decision-making for subsequent synthesis rounds, StarDrop™ enhances the discovery process's speed, efficiency, and overall productivity. Achieving a harmonious balance of various properties is crucial for the development of successful compounds. StarDrop™ effectively navigates the complexities of multi-parameter optimization, assisting users in identifying compounds with the greatest likelihood of success. Additionally, it conserves both time and resources by enabling the synthesis of fewer compounds and reducing the frequency of testing needed. As a result, researchers can focus their efforts more effectively, leading to more successful outcomes in their projects.

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

Palladium serves as a sophisticated software solution tailored for analyzing DNA encoded libraries, enabling virtual screenings and aiding in the prioritization of resynthesis tasks. This adaptable application accommodates a range of DEL designs and providers, functions seamlessly across major operating systems, and provides extensive support for data analytics. Furthermore, it optimizes research workflows by simplifying data organization and interpretation, ultimately leading to more effective and productive research outcomes. Researchers using Palladium can expect a significant boost in their ability to manage complex datasets efficiently.